TUG (ASPSCR1) Human shRNA Plasmid Kit (Locus ID 79058)
CAT#: TL307252
ASPSCR1 - Human, 4 unique 29mer shRNA constructs in lentiviral GFP vector, 5µg of each construct provided
Need custom shRNA service?
Get a free quote
CNY 7,740.00
Product images
CNY 4,070.00
Specifications
Product Data | |
Product Name | TUG (ASPSCR1) Human shRNA Plasmid Kit (Locus ID 79058) |
Locus ID | 79058 |
UniProt ID | Q9BZE9 |
Synonyms | ASPCR1; ASPL; ASPS; RCC17; TUG; UBXD9; UBXN9 |
Vector | pGFP-C-shLenti |
Format | Lentiviral plasmids |
Kit Components | ASPSCR1 - Human, 4 unique 29mer shRNA constructs in lentiviral GFP vector(Gene ID = 79058). 5µg purified plasmid DNA per construct29-mer scrambled shRNA cassette in pGFP-C-shLenti Vector, TR30021, included for free. |
RefSeq | NM_001251888, NM_001330528, NM_024083, NR_045351, NM_024083.1, NM_024083.2, NM_024083.3, NM_001251888.1, BC018722, BC018722.1, BC006152, NM_001251888.2, NM_024083.4 |
Summary | The protein encoded by this gene contains a UBX domain and interacts with glucose transporter type 4 (GLUT4). This protein is a tether, which sequesters the GLUT4 in intracellular vesicles in muscle and fat cells in the absence of insulin, and redistributes the GLUT4 to the plasma membrane within minutes of insulin stimulation. Translocation t(X;17)(p11;q25) of this gene with transcription factor TFE3 gene results in a ASPSCR1-TFE3 fusion protein in alveolar soft part sarcoma and in renal cell carcinomas. Multiple alternatively spliced transcript variants have been found. [provided by RefSeq, Oct 2011] |
shRNA Design | These shRNA constructs were designed against multiple splice variants at this gene locus. To be certain that your variant of interest is targeted, please contact techsupport@origene.com. If you need a special design or shRNA sequence, please utilize our custom shRNA service. |
Performance Guaranteed | OriGene guarantees that the sequences in the shRNA expression cassettes are verified to correspond to the target gene with 100% identity. One of the four constructs at minimum are guaranteed to produce 70% or more gene expression knock-down provided a minimum transfection efficiency of 80% is achieved. Western Blot data is recommended over qPCR to evaluate the silencing effect of the shRNA constructs 72 hrs post transfection. To properly assess knockdown, the gene expression level from the included scramble control vector must be used in comparison with the target-specific shRNA transfected samples. For non-conforming shRNA, requests for replacement product must be made within ninety (90) days from the date of delivery of the shRNA kit. To arrange for a free replacement with newly designed constructs, please contact Technical Services at techsupport@origene.com. Please provide your data indicating the transfection efficiency and measurement of gene expression knockdown compared to the scrambled shRNA control (Western Blot data preferred). |
Documents
Product Manuals |
FAQs |
SDS |
其它ASPSCR1产品